Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04377932 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer
Rhabdomyosarcoma
Malignant Rhabdoid Tumor
Liposarcoma
Wilms Tumor
Yolk Sac Tumor

Interventions

GENETIC: AGAR T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]